Some info on the effectiveness of Sativex (I think it's only available in Canada at the moment).

Sativex®, a Cannabis-Based Medicine, Significantly Reduces Central Neuropathic Pain in People with Multiple Sclerosis

27/09/2005

London, United Kingdom, 27th September 2005: The cannabis based medicine, Sativex®, is effective in reducing central neuropathic pain and sleep disturbance in people with Multiple Sclerosis (MS) in a UK study published today in the medical journal, Neurology1.
This randomised, controlled trial demonstrates ...

Some trial results for an oral drug - Laquimod

The results are to be presented during the ACTRIMS / ECTRIMS conference which takes place in the latter half of this week. No doubt other trial results will be presented - results for Tovaxin and NeuroVax are being presented.



Bromley

http://c.moreover.com/click/here.pl?j397362690&w=464753

The approval for a drug for MS sufferers who can't control their emotions has been delayed - not surprising that we can't control our emotions given that the drugs they create are either ineffective, kill, or are subject to delays!

http://c.moreover.com/click/here.pl?j395717806&w=464753

The following research paper suggests that cannaboids are useful in relation to neuro-degenerative / inflammatory diseases.


http://c.moreover.com/click/here.pl?j395340532&w=464753


The UK are funding some large scale trials into cannaboids as there is some evidence that they may ahve a neuro-protective effect -

Clinical Trials of cannabinoids as neuroprotective agents in MS
Professor John Zajicek, from the Peninsula Medical School in Plymouth, outlined the reasons for believing that some cannabinoids (chemicals derived ...

Clinical Trials In Multiple Sclerosis 2005:

Sorry having a hard time entering this link so try getting there through google. Second one down on google link


<shortened url>

This is an early trial for a drug for ALS but could also be of benefit to MS.

Bromley

http://c.moreover.com/click/here.pl?j388933782&w=464753

Another drugs company expanding into MS treatments


http://www.multicelltech.com/news/press_090705.htm

Bromley

Another t-reg experimental therapy...



Spanish scientists develop a cellular therapy for rheumatoid arthritis and multiple sclerosis

2005-09-09 -- A research team at the Institute of Parasitology and Biomedicine of the Spanish National Research Council (CSIC), in Grenade, has successfully developed in mice a cellular therapy for two major autoimmune diseases: rheumatoid arthritis and multiple sclerosis. The scientists succeeded, in both experimental models, in making the symptoms disappear and inducing a reversion of the degenerative process. ...

Dear all,

Not sure if this article has been posted before- it's about Neurovax and the experience of one triallist. Looks promising (like Tovaxin) - but don't they all! Probably a few years before it reaches thr market (if the trials are successful).

http://c.moreover.com/click/here.pl?j386259827&w=464753


Bromley

PS Apologies Dignan had already posted on this earlier. It was on the NZ MS site today so I assumed it was new news!

The Accelerated Cure project mentioned this small Phase I trial in their news section today. Riluzole is a drug for ALS. It's always good news when they test a drug for PPMS.



Glutamate inhibition in MS: the neuroprotective properties of riluzole

J Neurol Sci. 2005 Jun 15;233(1-2):113-5. Epub 2005 Apr 20.

Killestein J, Kalkers NF, Polman CH.
Department of Neurology, VU Medical Centre, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands. J.Killestein@vumc.nl ...